| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Regulatory | 60 | 2024 | 2988 | 5.700 |
Why?
|
| Transplantation Tolerance | 32 | 2021 | 617 | 5.280 |
Why?
|
| Immune Tolerance | 35 | 2024 | 2258 | 3.160 |
Why?
|
| Transplantation Immunology | 13 | 2018 | 546 | 2.680 |
Why?
|
| Graft Rejection | 42 | 2023 | 4397 | 2.600 |
Why?
|
| Forkhead Transcription Factors | 22 | 2019 | 1613 | 2.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 29 | 2018 | 4386 | 1.950 |
Why?
|
| T-Lymphocyte Subsets | 15 | 2019 | 1838 | 1.920 |
Why?
|
| Interleukin-2 | 20 | 2018 | 1904 | 1.820 |
Why?
|
| T-Lymphocytes | 31 | 2018 | 10180 | 1.750 |
Why?
|
| Organ Transplantation | 9 | 2024 | 1139 | 1.520 |
Why?
|
| Myeloid Differentiation Factor 88 | 10 | 2016 | 571 | 1.420 |
Why?
|
| Lymphocyte Activation | 39 | 2018 | 5524 | 1.420 |
Why?
|
| Kidney Transplantation | 14 | 2020 | 4251 | 1.380 |
Why?
|
| PTEN Phosphohydrolase | 9 | 2015 | 1142 | 1.250 |
Why?
|
| Lymphocyte Depletion | 9 | 2017 | 608 | 1.230 |
Why?
|
| Graft Survival | 19 | 2017 | 3737 | 1.160 |
Why?
|
| Autoimmunity | 7 | 2018 | 1349 | 1.100 |
Why?
|
| Receptors, Antigen, T-Cell | 16 | 2018 | 2540 | 1.090 |
Why?
|
| Homeostasis | 12 | 2018 | 3340 | 1.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 9 | 2018 | 2938 | 1.080 |
Why?
|
| Cell Differentiation | 25 | 2018 | 11483 | 1.010 |
Why?
|
| Immunosuppressive Agents | 19 | 2023 | 4149 | 1.000 |
Why?
|
| Signal Transduction | 35 | 2018 | 23403 | 0.950 |
Why?
|
| CD8-Positive T-Lymphocytes | 15 | 2020 | 4479 | 0.940 |
Why?
|
| Lymphocytic Choriomeningitis | 4 | 2017 | 132 | 0.900 |
Why?
|
| B-Lymphocytes | 11 | 2019 | 4665 | 0.860 |
Why?
|
| Immunologic Memory | 11 | 2020 | 1348 | 0.860 |
Why?
|
| Adoptive Transfer | 11 | 2016 | 844 | 0.810 |
Why?
|
| Animals | 127 | 2020 | 168757 | 0.800 |
Why?
|
| Self Tolerance | 4 | 2019 | 125 | 0.790 |
Why?
|
| Lymphocytic choriomeningitis virus | 3 | 2011 | 168 | 0.760 |
Why?
|
| Immunity, Innate | 9 | 2013 | 2958 | 0.730 |
Why?
|
| Lymphoma, T-Cell | 2 | 2014 | 299 | 0.730 |
Why?
|
| Thymus Gland | 6 | 2018 | 1267 | 0.710 |
Why?
|
| Receptors, Interleukin-2 | 10 | 2006 | 573 | 0.700 |
Why?
|
| Immunomodulation | 4 | 2018 | 541 | 0.690 |
Why?
|
| Cell Proliferation | 25 | 2019 | 10481 | 0.690 |
Why?
|
| Mice, Knockout | 33 | 2019 | 14557 | 0.680 |
Why?
|
| Mice | 90 | 2020 | 81183 | 0.680 |
Why?
|
| Skin Transplantation | 14 | 2017 | 1074 | 0.670 |
Why?
|
| Toll-Like Receptors | 4 | 2016 | 592 | 0.670 |
Why?
|
| Liver Transplantation | 7 | 2021 | 2119 | 0.660 |
Why?
|
| Immune System Diseases | 2 | 2011 | 262 | 0.640 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2018 | 130 | 0.610 |
Why?
|
| TNF Receptor-Associated Factor 6 | 7 | 2016 | 55 | 0.570 |
Why?
|
| Autoimmune Diseases | 5 | 2024 | 2133 | 0.550 |
Why?
|
| Transplantation, Homologous | 19 | 2016 | 4776 | 0.550 |
Why?
|
| Graft vs Host Disease | 6 | 2019 | 2957 | 0.540 |
Why?
|
| Energy Metabolism | 3 | 2018 | 2899 | 0.520 |
Why?
|
| Receptors, CCR6 | 1 | 2015 | 81 | 0.520 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 6 | 2018 | 310 | 0.500 |
Why?
|
| Periodicals as Topic | 3 | 2012 | 1432 | 0.490 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2017 | 548 | 0.490 |
Why?
|
| Toxoplasma | 4 | 2012 | 150 | 0.470 |
Why?
|
| Transforming Growth Factor beta | 4 | 2018 | 2007 | 0.470 |
Why?
|
| Mice, Inbred C57BL | 44 | 2019 | 21827 | 0.470 |
Why?
|
| Cell Lineage | 5 | 2018 | 2504 | 0.470 |
Why?
|
| Mice, Transgenic | 31 | 2018 | 9734 | 0.470 |
Why?
|
| Mice, Inbred BALB C | 25 | 2019 | 6386 | 0.460 |
Why?
|
| Interleukins | 2 | 2015 | 791 | 0.450 |
Why?
|
| Publishing | 2 | 2012 | 833 | 0.450 |
Why?
|
| Toxoplasmosis | 2 | 2010 | 91 | 0.440 |
Why?
|
| Toxoplasmosis, Animal | 2 | 2012 | 17 | 0.430 |
Why?
|
| CD40 Ligand | 9 | 2016 | 526 | 0.430 |
Why?
|
| Thymus Neoplasms | 1 | 2014 | 268 | 0.420 |
Why?
|
| Bone Marrow Transplantation | 8 | 2019 | 2765 | 0.400 |
Why?
|
| Antigens, CD | 8 | 2013 | 4026 | 0.400 |
Why?
|
| Gene Deletion | 7 | 2018 | 2751 | 0.400 |
Why?
|
| Cytokines | 12 | 2017 | 7322 | 0.390 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2010 | 25 | 0.380 |
Why?
|
| Cells, Cultured | 24 | 2020 | 19229 | 0.380 |
Why?
|
| Immunotherapy | 6 | 2017 | 4445 | 0.380 |
Why?
|
| Immunity, Cellular | 4 | 2013 | 1607 | 0.370 |
Why?
|
| Isoantigens | 7 | 2016 | 567 | 0.370 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 5 | 2015 | 805 | 0.370 |
Why?
|
| Th2 Cells | 6 | 2014 | 1061 | 0.370 |
Why?
|
| Interferon-gamma | 9 | 2012 | 3206 | 0.360 |
Why?
|
| Allergy and Immunology | 1 | 2011 | 169 | 0.360 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 7 | 2019 | 986 | 0.350 |
Why?
|
| Adaptive Immunity | 2 | 2011 | 713 | 0.350 |
Why?
|
| Models, Immunological | 4 | 2008 | 527 | 0.350 |
Why?
|
| Immunoconjugates | 5 | 2010 | 901 | 0.340 |
Why?
|
| Cell Survival | 11 | 2018 | 5882 | 0.340 |
Why?
|
| Retraction of Publication as Topic | 1 | 2008 | 10 | 0.340 |
Why?
|
| Adipocytes | 1 | 2016 | 1184 | 0.340 |
Why?
|
| Flow Cytometry | 13 | 2020 | 5974 | 0.340 |
Why?
|
| Dendritic Cells | 5 | 2020 | 2725 | 0.330 |
Why?
|
| Cell Division | 6 | 2005 | 4568 | 0.330 |
Why?
|
| Government Programs | 1 | 2010 | 275 | 0.320 |
Why?
|
| Glycolysis | 5 | 2018 | 827 | 0.320 |
Why?
|
| Scientific Misconduct | 1 | 2008 | 71 | 0.310 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2018 | 5442 | 0.310 |
Why?
|
| Antigen-Presenting Cells | 7 | 2018 | 973 | 0.310 |
Why?
|
| Lymphocytes | 2 | 2014 | 2617 | 0.310 |
Why?
|
| Macrophages | 3 | 2020 | 5655 | 0.300 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 1152 | 0.300 |
Why?
|
| Standard of Care | 1 | 2011 | 564 | 0.300 |
Why?
|
| Apoptosis | 14 | 2016 | 9727 | 0.300 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2007 | 708 | 0.280 |
Why?
|
| STAT5 Transcription Factor | 2 | 2006 | 259 | 0.280 |
Why?
|
| Clinical Medicine | 1 | 2008 | 147 | 0.280 |
Why?
|
| Sirolimus | 5 | 2020 | 1564 | 0.280 |
Why?
|
| Peer Review, Research | 1 | 2009 | 329 | 0.270 |
Why?
|
| Heart Transplantation | 11 | 2017 | 3110 | 0.270 |
Why?
|
| Humans | 88 | 2024 | 744343 | 0.270 |
Why?
|
| Clinical Trials as Topic | 5 | 2018 | 7913 | 0.270 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2008 | 880 | 0.250 |
Why?
|
| Interleukin-17 | 5 | 2013 | 899 | 0.250 |
Why?
|
| Poly I-C | 1 | 2004 | 115 | 0.240 |
Why?
|
| Clonal Anergy | 6 | 2008 | 169 | 0.230 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 625 | 0.230 |
Why?
|
| Multiple Sclerosis | 2 | 2019 | 3079 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2004 | 1434 | 0.220 |
Why?
|
| Living Donors | 3 | 2023 | 620 | 0.220 |
Why?
|
| Adjuvants, Immunologic | 3 | 2007 | 1000 | 0.220 |
Why?
|
| Killer Cells, Natural | 2 | 2011 | 2133 | 0.210 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2005 | 627 | 0.210 |
Why?
|
| Calcium Signaling | 3 | 2005 | 721 | 0.210 |
Why?
|
| CpG Islands | 1 | 2006 | 1172 | 0.210 |
Why?
|
| Politics | 1 | 2008 | 791 | 0.200 |
Why?
|
| Protein Kinase C | 1 | 2006 | 1227 | 0.200 |
Why?
|
| Tissue and Organ Procurement | 2 | 2012 | 896 | 0.200 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2015 | 835 | 0.200 |
Why?
|
| Lymphoma | 1 | 2010 | 1877 | 0.190 |
Why?
|
| ras Proteins | 1 | 2006 | 1060 | 0.190 |
Why?
|
| Transplantation, Autologous | 2 | 2018 | 2124 | 0.190 |
Why?
|
| Tacrolimus | 2 | 2023 | 743 | 0.180 |
Why?
|
| Autoantigens | 3 | 2020 | 892 | 0.180 |
Why?
|
| Chimera | 2 | 2014 | 485 | 0.180 |
Why?
|
| Evidence-Based Medicine | 2 | 2014 | 3610 | 0.180 |
Why?
|
| Transcription Factors | 6 | 2013 | 12208 | 0.180 |
Why?
|
| Organ Specificity | 2 | 2017 | 2008 | 0.180 |
Why?
|
| Electron Transport Complex III | 1 | 2019 | 31 | 0.170 |
Why?
|
| Insulin-Secreting Cells | 2 | 2020 | 891 | 0.170 |
Why?
|
| Biomedical Research | 3 | 2010 | 3309 | 0.170 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2018 | 24 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 5 | 2018 | 2503 | 0.160 |
Why?
|
| bcl-X Protein | 4 | 2004 | 411 | 0.160 |
Why?
|
| Skin | 3 | 2017 | 4364 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 8428 | 0.160 |
Why?
|
| Deoxyglucose | 1 | 2019 | 337 | 0.160 |
Why?
|
| Immunological Synapses | 1 | 2018 | 54 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2018 | 2109 | 0.160 |
Why?
|
| Interleukin-7 | 1 | 2018 | 142 | 0.160 |
Why?
|
| Growth Inhibitors | 3 | 2011 | 385 | 0.160 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 3 | 2012 | 906 | 0.160 |
Why?
|
| Intermediate Filaments | 1 | 2018 | 175 | 0.160 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2017 | 30 | 0.150 |
Why?
|
| Antigen Presentation | 6 | 2014 | 1284 | 0.150 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2019 | 890 | 0.150 |
Why?
|
| Vimentin | 1 | 2018 | 261 | 0.150 |
Why?
|
| Receptors, Cell Surface | 2 | 2004 | 2866 | 0.150 |
Why?
|
| Receptors, CXCR5 | 2 | 2016 | 92 | 0.150 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2017 | 226 | 0.150 |
Why?
|
| Calcineurin | 1 | 2018 | 226 | 0.150 |
Why?
|
| Lymphopoiesis | 1 | 2017 | 135 | 0.150 |
Why?
|
| Translocation, Genetic | 2 | 2014 | 1420 | 0.140 |
Why?
|
| OX40 Ligand | 2 | 2013 | 51 | 0.140 |
Why?
|
| Antibodies, Monoclonal | 10 | 2017 | 9274 | 0.140 |
Why?
|
| Gene Expression Regulation | 7 | 2019 | 12072 | 0.140 |
Why?
|
| Membrane Glycoproteins | 5 | 2011 | 3768 | 0.140 |
Why?
|
| Antilymphocyte Serum | 2 | 2010 | 492 | 0.140 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2010 | 780 | 0.140 |
Why?
|
| Conflict of Interest | 1 | 2021 | 544 | 0.140 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 481 | 0.140 |
Why?
|
| Membrane Proteins | 5 | 2014 | 7880 | 0.140 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2016 | 192 | 0.140 |
Why?
|
| Cell Movement | 3 | 2015 | 5217 | 0.130 |
Why?
|
| Withholding Treatment | 1 | 2020 | 599 | 0.130 |
Why?
|
| Th1 Cells | 5 | 2014 | 1057 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2007 | 3743 | 0.130 |
Why?
|
| Amine Oxidase (Copper-Containing) | 1 | 2014 | 41 | 0.130 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2015 | 79 | 0.130 |
Why?
|
| Hydrolases | 1 | 2015 | 139 | 0.130 |
Why?
|
| Tissue Donors | 3 | 2018 | 2240 | 0.130 |
Why?
|
| Germinal Center | 1 | 2017 | 377 | 0.130 |
Why?
|
| Stem Cell Transplantation | 1 | 2004 | 1620 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2017 | 3920 | 0.130 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 18029 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2014 | 342 | 0.120 |
Why?
|
| Proteins | 3 | 2005 | 6103 | 0.120 |
Why?
|
| Receptors, OX40 | 2 | 2011 | 43 | 0.120 |
Why?
|
| Endothelium, Vascular | 5 | 2005 | 4456 | 0.120 |
Why?
|
| Chromosomes, Mammalian | 1 | 2014 | 151 | 0.120 |
Why?
|
| Hematopoiesis | 1 | 2003 | 2072 | 0.120 |
Why?
|
| Down-Regulation | 4 | 2005 | 3002 | 0.120 |
Why?
|
| Obesity | 1 | 2016 | 12745 | 0.120 |
Why?
|
| Gene Expression Profiling | 4 | 2018 | 9438 | 0.110 |
Why?
|
| Antigens, Differentiation | 4 | 2005 | 927 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2020 | 3336 | 0.110 |
Why?
|
| Interleukin-10 | 3 | 2012 | 1200 | 0.110 |
Why?
|
| Nasal Provocation Tests | 1 | 2012 | 9 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 1 | 2020 | 795 | 0.110 |
Why?
|
| Antibody Formation | 1 | 2017 | 1402 | 0.110 |
Why?
|
| Cooperative Behavior | 2 | 2010 | 1504 | 0.110 |
Why?
|
| NF-kappa B | 2 | 2016 | 2499 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 987 | 0.110 |
Why?
|
| Basophils | 1 | 2014 | 389 | 0.110 |
Why?
|
| Salmonella Infections, Animal | 1 | 2012 | 65 | 0.110 |
Why?
|
| DNA Primers | 1 | 2017 | 2892 | 0.110 |
Why?
|
| Pollen | 1 | 2012 | 75 | 0.110 |
Why?
|
| Up-Regulation | 5 | 2004 | 4217 | 0.110 |
Why?
|
| Clone Cells | 2 | 2008 | 1692 | 0.110 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 2187 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 11725 | 0.100 |
Why?
|
| Enteritis | 1 | 2013 | 165 | 0.100 |
Why?
|
| Research | 2 | 2012 | 1999 | 0.100 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2012 | 99 | 0.100 |
Why?
|
| Models, Animal | 4 | 2017 | 2171 | 0.100 |
Why?
|
| Immunogenetics | 1 | 2011 | 67 | 0.100 |
Why?
|
| Interleukin-23 | 1 | 2013 | 193 | 0.100 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2011 | 67 | 0.100 |
Why?
|
| Cell Compartmentation | 1 | 2012 | 402 | 0.100 |
Why?
|
| Gastritis | 1 | 2013 | 196 | 0.100 |
Why?
|
| Phosphorylation | 4 | 2016 | 8436 | 0.100 |
Why?
|
| Lymphoid Tissue | 1 | 2013 | 455 | 0.100 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2014 | 629 | 0.100 |
Why?
|
| Antibodies | 2 | 2013 | 2460 | 0.100 |
Why?
|
| Primates | 1 | 2013 | 545 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 2006 | 1475 | 0.100 |
Why?
|
| Autoimmune Lymphoproliferative Syndrome | 1 | 2010 | 13 | 0.090 |
Why?
|
| STAT1 Transcription Factor | 2 | 2012 | 320 | 0.090 |
Why?
|
| Mitochondria | 2 | 2019 | 3520 | 0.090 |
Why?
|
| Stem Cells | 1 | 2004 | 3567 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3870 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2011 | 2740 | 0.090 |
Why?
|
| Inflammation | 6 | 2019 | 10638 | 0.090 |
Why?
|
| Desensitization, Immunologic | 2 | 2014 | 483 | 0.090 |
Why?
|
| Chimerism | 1 | 2011 | 158 | 0.090 |
Why?
|
| Immunity | 1 | 2016 | 1012 | 0.090 |
Why?
|
| Th17 Cells | 2 | 2014 | 766 | 0.090 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 853 | 0.090 |
Why?
|
| Protein Isoforms | 1 | 2014 | 1730 | 0.090 |
Why?
|
| Phenotype | 5 | 2018 | 16365 | 0.090 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2012 | 337 | 0.090 |
Why?
|
| Cholesterol | 1 | 2018 | 2917 | 0.080 |
Why?
|
| Interleukin-1 | 1 | 2013 | 1263 | 0.080 |
Why?
|
| Mice, SCID | 3 | 2016 | 2716 | 0.080 |
Why?
|
| Homicide | 1 | 2012 | 287 | 0.080 |
Why?
|
| Radiation Chimera | 2 | 2011 | 223 | 0.080 |
Why?
|
| Lectins, C-Type | 1 | 2012 | 588 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 1677 | 0.080 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2014 | 745 | 0.080 |
Why?
|
| Eosinophilia | 1 | 2013 | 541 | 0.080 |
Why?
|
| Allergens | 2 | 2014 | 1320 | 0.080 |
Why?
|
| Receptors, Virus | 1 | 2012 | 648 | 0.080 |
Why?
|
| Prisoners | 1 | 2012 | 297 | 0.080 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2008 | 22 | 0.080 |
Why?
|
| Eosinophils | 1 | 2013 | 955 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 905 | 0.080 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2010 | 431 | 0.080 |
Why?
|
| Lymphocyte Subsets | 1 | 2009 | 315 | 0.080 |
Why?
|
| Interleukin-6 | 2 | 2008 | 3200 | 0.080 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2016 | 1270 | 0.080 |
Why?
|
| Liver Diseases | 1 | 2016 | 1253 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2011 | 959 | 0.080 |
Why?
|
| Spleen | 5 | 2012 | 2362 | 0.080 |
Why?
|
| Female | 24 | 2020 | 380194 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2006 | 5179 | 0.070 |
Why?
|
| Gene Expression | 2 | 2018 | 7799 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2009 | 477 | 0.070 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2011 | 298 | 0.070 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2005 | 290 | 0.070 |
Why?
|
| Editorial Policies | 1 | 2012 | 451 | 0.070 |
Why?
|
| Receptors, Interleukin-15 | 1 | 2006 | 16 | 0.070 |
Why?
|
| Treatment Outcome | 9 | 2017 | 63114 | 0.070 |
Why?
|
| Acute Disease | 4 | 2016 | 7149 | 0.070 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2008 | 262 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 6622 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 1956 | 0.070 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2007 | 78 | 0.070 |
Why?
|
| Genes | 1 | 2010 | 1893 | 0.070 |
Why?
|
| Mice, Inbred Strains | 3 | 2004 | 1827 | 0.070 |
Why?
|
| Tamoxifen | 1 | 2011 | 981 | 0.070 |
Why?
|
| Models, Biological | 3 | 2008 | 9583 | 0.070 |
Why?
|
| Mice, Inbred CBA | 4 | 2012 | 448 | 0.070 |
Why?
|
| Coculture Techniques | 6 | 2007 | 1341 | 0.070 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2005 | 123 | 0.070 |
Why?
|
| China | 1 | 2012 | 2248 | 0.070 |
Why?
|
| HTLV-I Infections | 1 | 2006 | 101 | 0.070 |
Why?
|
| Second Messenger Systems | 1 | 2006 | 206 | 0.070 |
Why?
|
| Male | 22 | 2020 | 350118 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2010 | 1526 | 0.070 |
Why?
|
| Interleukin-15 | 1 | 2006 | 184 | 0.070 |
Why?
|
| Base Sequence | 1 | 2017 | 12797 | 0.070 |
Why?
|
| Mice, Inbred NOD | 3 | 2016 | 1878 | 0.070 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2003 | 246 | 0.060 |
Why?
|
| Diffusion of Innovation | 1 | 2010 | 725 | 0.060 |
Why?
|
| Informed Consent | 1 | 2012 | 995 | 0.060 |
Why?
|
| Antigens, Protozoan | 1 | 2007 | 322 | 0.060 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2005 | 127 | 0.060 |
Why?
|
| Glycine | 1 | 2008 | 671 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2018 | 40561 | 0.060 |
Why?
|
| Mice, Inbred DBA | 3 | 2012 | 642 | 0.060 |
Why?
|
| Time Factors | 9 | 2017 | 40075 | 0.060 |
Why?
|
| Public Opinion | 1 | 2008 | 477 | 0.060 |
Why?
|
| Patient Selection | 3 | 2017 | 4215 | 0.060 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 2513 | 0.060 |
Why?
|
| Bone Marrow | 1 | 2014 | 2948 | 0.060 |
Why?
|
| Retroviridae | 2 | 2004 | 914 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 2538 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2017 | 3772 | 0.060 |
Why?
|
| Intestines | 1 | 2013 | 1924 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2004 | 2849 | 0.060 |
Why?
|
| Public Policy | 1 | 2008 | 572 | 0.060 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2004 | 91 | 0.060 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2006 | 207 | 0.060 |
Why?
|
| International Cooperation | 1 | 2010 | 1420 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2007 | 1366 | 0.060 |
Why?
|
| Program Development | 1 | 2010 | 1316 | 0.060 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 873 | 0.060 |
Why?
|
| Bystander Effect | 1 | 2003 | 81 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 595 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2004 | 4554 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2006 | 1682 | 0.060 |
Why?
|
| Milk Proteins | 1 | 2003 | 169 | 0.060 |
Why?
|
| Transplants | 1 | 2005 | 209 | 0.050 |
Why?
|
| Isoantibodies | 2 | 2017 | 679 | 0.050 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 292 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 9648 | 0.050 |
Why?
|
| Interleukin-4 | 3 | 2013 | 1147 | 0.050 |
Why?
|
| Neoplasms | 3 | 2018 | 21683 | 0.050 |
Why?
|
| Interleukin-18 | 1 | 2003 | 249 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2007 | 789 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2006 | 1801 | 0.050 |
Why?
|
| Species Specificity | 2 | 2003 | 2478 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 1889 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2021 | 1836 | 0.050 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2004 | 354 | 0.050 |
Why?
|
| Tyrosine | 1 | 2006 | 1461 | 0.050 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2002 | 142 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 473 | 0.050 |
Why?
|
| Mice, Mutant Strains | 2 | 2019 | 1866 | 0.050 |
Why?
|
| Mice, Inbred C3H | 3 | 2010 | 964 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 3597 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2023 | 343 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 1782 | 0.050 |
Why?
|
| Chronic Disease | 3 | 2019 | 9146 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 565 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2005 | 1663 | 0.050 |
Why?
|
| Prospective Studies | 4 | 2020 | 53288 | 0.050 |
Why?
|
| Risk Factors | 3 | 2024 | 72290 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2016 | 3752 | 0.050 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2003 | 523 | 0.040 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 1912 | 0.040 |
Why?
|
| Tumor Necrosis Factors | 2 | 2011 | 109 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 3848 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1285 | 0.040 |
Why?
|
| Lung | 1 | 2017 | 9856 | 0.040 |
Why?
|
| Registries | 2 | 2014 | 8089 | 0.040 |
Why?
|
| Protein Binding | 2 | 2009 | 9386 | 0.040 |
Why?
|
| Transplantation Chimera | 2 | 2017 | 612 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2011 | 2303 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2004 | 1534 | 0.040 |
Why?
|
| Integrins | 1 | 2003 | 846 | 0.040 |
Why?
|
| Scleroderma, Localized | 1 | 2019 | 79 | 0.040 |
Why?
|
| Succinic Acid | 1 | 2019 | 83 | 0.040 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2018 | 517 | 0.040 |
Why?
|
| T-Box Domain Proteins | 2 | 2012 | 471 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5221 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 2942 | 0.040 |
Why?
|
| Electron Transport | 1 | 2019 | 211 | 0.040 |
Why?
|
| Colitis | 1 | 2006 | 1170 | 0.040 |
Why?
|
| Steroids | 1 | 2023 | 930 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2004 | 1423 | 0.040 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2019 | 192 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2004 | 643 | 0.040 |
Why?
|
| Protein Multimerization | 2 | 2014 | 970 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2008 | 2916 | 0.040 |
Why?
|
| Glutarates | 1 | 2019 | 236 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2009 | 2494 | 0.040 |
Why?
|
| Ligands | 1 | 2004 | 3282 | 0.040 |
Why?
|
| Transplantation Conditioning | 1 | 2004 | 1598 | 0.040 |
Why?
|
| Receptors, Cytokine | 2 | 2011 | 261 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 2216 | 0.040 |
Why?
|
| Internet | 1 | 2008 | 3064 | 0.030 |
Why?
|
| Glucose | 2 | 2019 | 4397 | 0.030 |
Why?
|
| Kinetics | 2 | 2019 | 6473 | 0.030 |
Why?
|
| Disease Progression | 2 | 2016 | 13284 | 0.030 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2015 | 78 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2020 | 4286 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2008 | 10252 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2002 | 1821 | 0.030 |
Why?
|
| Metabolism | 1 | 2016 | 196 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 1861 | 0.030 |
Why?
|
| United States | 4 | 2010 | 69872 | 0.030 |
Why?
|
| Ovalbumin | 2 | 2007 | 719 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2003 | 2924 | 0.030 |
Why?
|
| Mutation | 3 | 2017 | 29786 | 0.030 |
Why?
|
| Conjunctivitis | 1 | 2014 | 158 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2013 | 199 | 0.030 |
Why?
|
| Calcium | 1 | 2006 | 5756 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 578 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 157 | 0.030 |
Why?
|
| Phleum | 1 | 2012 | 3 | 0.030 |
Why?
|
| Receptors, IgE | 1 | 2014 | 389 | 0.030 |
Why?
|
| Eosinophil Cationic Protein | 1 | 2012 | 9 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1655 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 1654 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 13102 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2018 | 2559 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 783 | 0.030 |
Why?
|
| Middle Aged | 5 | 2020 | 213383 | 0.030 |
Why?
|
| Weight Loss | 1 | 2003 | 2622 | 0.030 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2013 | 140 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2014 | 684 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2012 | 273 | 0.030 |
Why?
|
| Lymph Nodes | 3 | 2012 | 3474 | 0.020 |
Why?
|
| Receptors, CXCR3 | 1 | 2012 | 237 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 5319 | 0.020 |
Why?
|
| Tryptases | 1 | 2012 | 190 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2017 | 1381 | 0.020 |
Why?
|
| Physicians | 1 | 2009 | 4567 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2012 | 6489 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 1641 | 0.020 |
Why?
|
| Homeodomain Proteins | 2 | 2013 | 2421 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 635 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2634 | 0.020 |
Why?
|
| Salmonella typhimurium | 1 | 2012 | 351 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2012 | 389 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8324 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1119 | 0.020 |
Why?
|
| Metagenome | 1 | 2013 | 418 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2010 | 352 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2010 | 156 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2010 | 180 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2183 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 5853 | 0.020 |
Why?
|
| Galectins | 1 | 2012 | 268 | 0.020 |
Why?
|
| Metabolomics | 1 | 2018 | 1484 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 2 | 2002 | 936 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2010 | 171 | 0.020 |
Why?
|
| Histocompatibility | 1 | 2010 | 330 | 0.020 |
Why?
|
| ROC Curve | 1 | 2017 | 3527 | 0.020 |
Why?
|
| Prognosis | 2 | 2011 | 29063 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2014 | 1463 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2010 | 277 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2014 | 1462 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 1701 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2007 | 99 | 0.020 |
Why?
|
| DNA | 1 | 2002 | 7301 | 0.020 |
Why?
|
| Adult | 6 | 2020 | 214055 | 0.020 |
Why?
|
| Kidney | 1 | 2023 | 7186 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2014 | 1116 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 11366 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2008 | 119 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2014 | 1352 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2008 | 253 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 6171 | 0.020 |
Why?
|
| Rhinitis | 1 | 2014 | 691 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3647 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 19905 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2006 | 5686 | 0.020 |
Why?
|
| 4-1BB Ligand | 1 | 2006 | 29 | 0.020 |
Why?
|
| Financing, Government | 1 | 2010 | 468 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 1792 | 0.020 |
Why?
|
| Young Adult | 3 | 2020 | 56430 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2010 | 705 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2017 | 23338 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 2505 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2019 | 12026 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2007 | 494 | 0.020 |
Why?
|
| Oxygen | 1 | 2016 | 4189 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 4560 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2004 | 195 | 0.020 |
Why?
|
| Transcription Factor RelB | 1 | 2003 | 29 | 0.010 |
Why?
|
| Rabbits | 1 | 2010 | 4894 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 2005 | 457 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2004 | 198 | 0.010 |
Why?
|
| Cell Membrane | 2 | 2003 | 3748 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 203 | 0.010 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2004 | 152 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1547 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 5867 | 0.010 |
Why?
|
| Phospholipase C gamma | 1 | 2003 | 128 | 0.010 |
Why?
|
| Interphase | 1 | 2003 | 226 | 0.010 |
Why?
|
| Histone Deacetylases | 1 | 2007 | 728 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2003 | 791 | 0.010 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2002 | 130 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2002 | 318 | 0.010 |
Why?
|
| Perforin | 1 | 2002 | 168 | 0.010 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2002 | 159 | 0.010 |
Why?
|
| Child | 3 | 2016 | 77709 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 2010 | 1584 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2012 | 1863 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2016 | 41006 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 16689 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 928 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2006 | 1880 | 0.010 |
Why?
|
| Exocytosis | 1 | 2002 | 353 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15076 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 1454 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 2002 | 471 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2003 | 502 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2003 | 913 | 0.010 |
Why?
|
| Health Care Reform | 1 | 2009 | 1261 | 0.010 |
Why?
|
| Survival Rate | 1 | 2014 | 12788 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 1157 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 2759 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2002 | 1137 | 0.010 |
Why?
|
| Epitopes | 1 | 2006 | 2571 | 0.010 |
Why?
|
| Endocytosis | 1 | 2003 | 985 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 669 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2003 | 739 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2002 | 1369 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6538 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2005 | 3689 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4751 | 0.010 |
Why?
|
| Parents | 1 | 2012 | 3407 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2009 | 1901 | 0.010 |
Why?
|
| Cell Death | 1 | 2003 | 1706 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 18370 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 14722 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3701 | 0.010 |
Why?
|
| Cell Separation | 1 | 2002 | 1751 | 0.010 |
Why?
|
| Liver | 1 | 2012 | 7474 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 1526 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2003 | 1990 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 163280 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39050 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15540 | 0.010 |
Why?
|
| Peptides | 1 | 2005 | 4409 | 0.010 |
Why?
|
| RNA | 1 | 2002 | 2749 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 85781 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 5097 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 7722 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 35136 | 0.010 |
Why?
|
| Myocardium | 1 | 2002 | 4776 | 0.010 |
Why?
|